Evidence map›Paper›PMID 36535096›Full record

SynthesisDrug and alcohol dependence2023

A systematic review of brief, freely accessible, and valid self-report measures for substance use disorders and treatment.

Rebecca E Stewart, Nicholas C Cardamone, Allison Schachter, Chloe Becker, James R McKay, Emily M Becker-Haimes

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Drug and alcohol dependence, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Wellbeing trajectories and dementia risk among Mexican-origin adults living in the U.S.Health psychology : official journal of the Division of Health Psychology, American Psychological Association · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Rebecca E StewartUniversity of Pennsylvania, Department of Psychiatry, Philadelphia, PA 19104, USA. Electronic address: Rebecca.Stewart@pennmedicine.upenn.edu.
Nicholas C CardamoneUniversity of Pennsylvania, Department of Psychiatry, Philadelphia, PA 19104, USA. Electronic address: Nicholas.Cardamone@pennmedicine.upenn.edu.
Allison SchachterUniversity of Pennsylvania, Department of Psychiatry, Philadelphia, PA 19104, USA. Electronic address: aschach@sas.upenn.edu.
Chloe BeckerGeorge Washington University School of Medicine and Health Sciences, Ross Hall, 2300 Eye Street, NW, Washington, D.C. 20037, USA. Electronic address: cbecker@gwu.edu.
James R McKayUniversity of Pennsylvania, Department of Psychiatry, Philadelphia, PA 19104, USA; Crescenz Department of Veteran Affairs Medical Center, 3900 Woodland Ave, Philadelphia, PA 19104, USA. Electronic address: jimrache@pennmedicine.upenn.edu.
Emily M Becker-HaimesUniversity of Pennsylvania, Department of Psychiatry, Philadelphia, PA 19104, USA; Hall Mercer Community Mental Health, University of Pennsylvania, 800 Spruce St, Philadelphia, PA 19107, USA. Electronic address: emily.haimes@pennmedicine.upenn.edu.
University of Pennsylvania · USGeorge Washington University · USPenn Center for AIDS Research · USPhiladelphia VA Medical Center · US

Funding

Adaptive Treatment Models for the Management of Drug Use DisordersK24DA029062 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI MCKAY, JAMES R. · 2010 to 2021
$1.6M
Increasing the uptake of medication-assisted treatment for opioid use disorderK23DA048167 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI STEWART, REBECCA E · 2019 to 2023
$975k
NIDA NIH HHS K23 DA048167NIDA NIH HHS K24 DA029062
6 · The paper itself

Abstract

backgroundSelf-report measures can improve evidence-based assessment practices in substance use disorder treatment, but many measures are burdensome and costly, limiting their utility in community practice and non-specialty healthcare settings. This systematic review identified and evaluated the psychometric properties of brief, free, and readily accessible self-report measures of substance use and related factors.

methodsWe searched two electronic databases (PsycINFO and PubMed) in May 2021 for published literature on scales, measures, or instruments related to substance use, substance use treatment, and recovery, and extracted the names of all measures. Measures were included if they were: (1) brief (25 items or fewer), (2) freely accessible in a ready-to-use format, and (3) had published psychometric data.

resultsAn initial search returned 411 measures, of which 73 (18%) met criteria for inclusion. Included measures assessed a variety of substances (e.g., alcohol, nicotine, opioids, cannabinoids, cocaine) and measurement domains (e.g., use, severity, expectancies, withdrawal). Among these measures, 14 (19%) were classified as psychometrically "excellent," 27 (37%) were rated as "good," 32 (44%) were "adequate."

conclusionsDespite the shift toward evidence-based assessment in substance use disorder treatment in the last twenty years, key areas of public health concern are lacking pragmatic, psychometrically valid measures. Among the brief measures we reviewed, less than a fifth met criteria for psychometric "excellence" and most of these instruments fell into one measurement domain: screening for problematic substance use. Future research should focus both on improving the evidence base for existing brief self-report measures and creating new low-burden measures for specific substances and treatment constructs.

Indexed as

Substance-Related DisordersDelivery of Health CareHumansNicotinePsychometricsSelf ReportNicotineAssessmentCommunity settingsScreeningSelf-report measuresSubstance use disorder

Identifiers

PMID36535096
PMCPMC9872256
OpenAlexW4312019320

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.